Ingrezza – Display Banners TD Therapeutic Spotlight – 25964
Tardive Dyskinesia eBook
Focus on Tardive Dyskinesia
Why Is Age a Key Risk Factor for Tardive Dyskinesia?
Tardive dyskinesia (TD) is up to five to six times more prevalent in elderly adults compared with...
No Association Between Tardive Dyskinesia & Mortality
Compared with the general population, patients with severe mental illness (SMI) have a shortened...
TD Movements Negatively Impact Professional & Social Perceptions
In professional and social situations, professional actors simulating tardive dyskinesia (TD)...
Direct Current Stimulation Reduces Abnormal Movements in Tardive Dyskinesia
Although diagnosed schizophrenia can be managed through pharmacologic intervention, side effects...
Blood Biomarkers May Assist in Diagnosing Schizophrenia With Tardive Dyskinesia
Certain blood biochemical markers may have an important role in the pathogenesis of schizophrenia...
Tardive Dyskinesia is a Clinical Phenotype in Bipolar Disorder (BD)
For a study, the researchers sought to determine the clinical correlates and antipsychotic use...
Defining Utility Values for Tardive Dyskinesia (TD) Patients
For a study, the researcher sought to assess health-state preferences and estimate utility values...
Impact of DIP & Tardive Dyskinesia on Health-Related Quality of Life (HRQOL) in Schizophrenia
The researchers sought to determine and compare the relationship between drug-induced Parkinsonism...
Long-Term Deutetrabenazine Treatment for TD Is Associated With Sustained Benefits & Safety
For a study, the researchers sought to conduct a single-arm, open-label extension (OLE) study to...
